Assignee
TVARDI THERAPEUTICS INC
US·6 granted patents·5 pending applications·15 citations·filing 2019–2024
Top patents by PatentIndex Score
11 records- 0192US11026905B2STAT3 inhibitorsTVARDI THERAPEUTICS INC·Filed 2020·Granted Jun 8, 2021·5 cites·6 claims
- 0291US11077077B1Therapeutic compounds, formulations, and uses thereofTVARDI THERAPEUTICS INC·Filed 2021·Granted Aug 3, 2021·5 cites·19 claims
- 0389US11547683B2Therapeutic compounds, formulations, and uses thereofTVARDI THERAPEUTICS INC·Filed 2021·Granted Jan 10, 2023·2 cites·19 claims
- 0488US12043640B2Prodrugs of STAT3 inhibitorsTVARDI THERAPEUTICS INC·Filed 2023·Granted Jul 23, 2024·1 cites·14 claims
- 0583US11826315B2STAT3 inhibitorsTVARDI THERAPEUTICS INC·Filed 2019·Granted Nov 28, 2023·2 cites·11 claims
- 0674US12053444B2Therapeutic compounds, formulations, and uses thereofTVARDI THERAPEUTICS INC·Filed 2022·Granted Aug 6, 2024·0 cites·20 claims
- 0771US2024058284A1Stat3 inhibitorsTVARDI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0869US2024327438A1Prodrugs of stat3 inhibitorsTVARDI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0961US2025170079A1Combinations of stat-inhibitors and immune checkpoint inhibitors for the treatment and/or management of cancerTVARDI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1061US2024033234A1Therapeutic compounds, formulations, and use thereofTVARDI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1161US2025170065A1Therapeutic compounds, formulations, and use thereofTVARDI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →